EU regulator rejects Alzheimer’s drug lecanemab
- Saturday, July 27, 2024, 7:01
- Health, Sports
- Add a comment
It said the benefits of the treatment did not outweigh the risk of serious side effects.
About the Author
adminasapcorp has written 38727 stories on this site.